MLTX
MoonLakeยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
MLTX Profile
Moonlake Immunotherapeutics.
A clinical-stage biotech company that develops medicines for immunologic diseases, including inflammatory skin and joint diseases
Biological Technology
08/13/2020
10/20/2020
NASDAQ Stock Exchange
100
12-31
Common stock
Dorfstrasse 29, 6300 Zug, Switzerland
--
MoonLake Immunotherapeutics. A Cayman Islands company registered on August 13, 2020, MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing transformative therapies to address significant unmet needs in inflammatory skin and joint diseases.
